MPWT
SRPT icon

MassMutual Private Wealth & Trust’s Sarepta Therapeutics SRPT Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39K Buy
133
+34
+34% +$643 ﹤0.01% 1951
2026
Q1 		$2.15K Sell
99
-1
-1% -$19 ﹤0.01% 1961
2025
Q4 		$2.15K Sell
100
-10
-9% -$211 ﹤0.01% 1976
2025
Q3 		$2.12K Sell
110
-218
-66% -$3.89K ﹤0.01% 1964
2025
Q2 		$5.61K Buy
328
+130
+66% +$5.55K ﹤0.01% 1591
2025
Q1 		$12.6K Sell
198
-50
-20% -$5.26K ﹤0.01% 1210
2024
Q4 		$30.2K Buy
248
+156
+170% +$19.1K ﹤0.01% 873
2024
Q3 		$11.5K Sell
92
-21
-19% -$2.9K ﹤0.01% 1092
2024
Q2 		$17.9K Buy
113
+66
+140% +$8.48K ﹤0.01% 888
2024
Q1 		$6.08K Buy
47
+5
+12% +$612 ﹤0.01% 1201
2023
Q4 		$4.05K Buy
42
+13
+45% +$1.25K ﹤0.01% 1292
2023
Q3 		$3.52K Sell
29
-6
-17% -$678 ﹤0.01% 1356
2023
Q2 		$4.01K Buy
35
+5
+17% +$645 ﹤0.01% 1277
2023
Q1 		$4.13K Hold
30
– – ﹤0.01% 1199
2022
Q4 		$4K Buy
30
+3
+11% +$348 ﹤0.01% 1098
2022
Q3 		$3K Buy
27
+20
+286% +$2.02K ﹤0.01% 1135
2022
Q2 		$1K Sell
7
-2
-22% -$147 ﹤0.01% 1418
2022
Q1 		$1K Sell
9
-7
-44% -$536 ﹤0.01% 1426
2021
Q4 		$1K Buy
16
+7
+78% +$598 ﹤0.01% 1306
2021
Q3 		$1K Hold
9
– – ﹤0.01% 1217
2021
Q2 		$1K Buy
+9
New +$682 ﹤0.01% 1172
2019
Q1 		– Sell
-90
Closed -$9.82K – 980
2018
Q4 		$9.82K Sell
90
-32
-26% -$4K ﹤0.01% 569
2018
Q3 		$19.7K Sell
122
-2
-2% -$273 ﹤0.01% 508
2018
Q2 		$16.4K Hold
124
– – ﹤0.01% 534
2018
Q1 		$9.19K Buy
124
+104
+520% +$6.93K ﹤0.01% 608
2017
Q4 		$1.11K Buy
+20
New +$1.06K ﹤0.01% 824

Other funds holding SRPT

EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

MassMutual Private Wealth & Trust's SRPT Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Sarepta Therapeutics (SRPT) stake by 34% in Q2 2026, buying an estimated $643 and bringing the position to 133 shares worth $2.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1951.

MassMutual Private Wealth & Trust first reported a position in SRPT in Q4 2017 and has held it in 26 quarters since. The position peaked at $30.2K in Q4 2024. 72 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • MassMutual Private Wealth & Trust held 133 shares of Sarepta Therapeutics worth $2.39K as of Q2 2026.
  • MassMutual Private Wealth & Trust bought 34 Sarepta Therapeutics shares in Q2 2026, an estimated $643.
  • Sarepta Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1951 holding.
  • MassMutual Private Wealth & Trust first reported a position in Sarepta Therapeutics in Q4 2017 and has held it in 26 quarters since.
  • MassMutual Private Wealth & Trust's Sarepta Therapeutics position peaked at $30.2K in Q4 2024.
  • 72 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.